Enzalutamida en este contexto (CPRC): ¿cuáles son los pacientes? - page 42

THANK YOU

Javier Puente, MD, PhD

Hospital Universitario Clinico San Carlos

Medical Oncology Department

Comp utense University

Associate Professor of Medicine

SEO Version

Warning.

You are currently viewing the SEO version of !text.
It has a number of design and functionality limitations.

We recommend viewing the Flash version or the basic HTML version of this publication.

1...,32,33,34,35,36,37,38,39,40,41 42